Stem Cells World Congress
Recommend Cell Cycle to your librarian for 2008. Download form here.

Sign up for Table of Contents Alerts.

home subscribe search archive forthcoming

Email this page Print this page

Brief Report

The nucleolar phosphatase Cdc14B is dispensable for chromosome segregation and mitotic exit in human cells

Eli Berdougo, Maxence V. Nachury, Peter K. Jackson and Prasad V. Jallepalli

volume 7 | issue 9

1 May 2008
Pages: 1184 - 1190

Purchase article for $19

Subscribe to this journal for $129/year

In yeast, the protein phosphatase Cdc14 promotes chromosome segregation, mitotic exit, and cytokinesis by reversing M-phase phosphorylations catalyzed by Cdk1. A key feature of Cdc14 regulation is its sequestration within the nucleolus, which restricts its access to potential substrates for much of the cell cycle. Mammals also possess a nucleolar Cdc14 homolog, termed Cdc14B, but its roles during mitosis and cell division remain speculative. Here we analyze Cdc14B’s subcellular dynamics during mitosis and rigorously test its functional contributions to cell division through homozygous disruption of the Cdc14B locus in human somatic cells. While Cdc14B is initially released from nucleoli at the start of mitosis, the phosphatase quickly redistributes onto segregating sister chromatids during anaphase. This relocalization is mainly driven by Cdk1 inactivation, as pharmacologic inhibition of Cdk1 in prometaphase cells redirects Cdc14B onto chromosomes. However, in sharp contrast to yeast cdc14 mutants, human Cdc14BΔ/Δ cells were viable and lacked defects in spindle assembly, anaphase progression, mitotic exit, and cytokinesis, and continued to segregate ribosomal DNA repeats with near-normal proficiency. Our findings reveal substantial divergence in mitotic regulation between yeast and mammalian cells, as the latter possess efficient mechanisms for completing late M-phase events in the absence of a nucleolar Cdc14-related phosphatase.

Authors

Eli Berdougo

Memorial Sloan-Kettering Cancer Center; New York, NY

Maxence V. Nachury

Stanford University School of Medicine; Palo Alto, CA

Peter K. Jackson

Stanford University School of Medicine; Palo Alto, CA

Prasad V. Jallepalli

Memorial Sloan-Kettering Cancer Center; New York, NY


Purchase article for $19

Subscribe to this journal for $129/year